Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to characterise the blood pharmacokinetic profile of oral immediate-release cysteamine (Cystagon) when administered to patients with Cystic Fibrosis at the dose licensed for use in cystinosis.
Critère d'inclusion
- Cystic fibrosis